Related Experiment Video
Updated: Jun 7, 2025

11:52
Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
Published on: August 4, 2016
10.3K
An optimized workflow of full-length transcriptome sequencing for accurate fusion transcript identification.
Liang Zong1,2, Yabing Zhu3, Yuan Jiang2
1Department of Biology and Genetics, College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.
RNA Biology
|November 14, 2024
Summary
This study introduces an optimized nanopore sequencing workflow for precise fusion gene detection in cancer genomics. The enhanced method improves accuracy and aids clinical diagnostics by identifying novel fusion events.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Next-generation sequencing (NGS) advances cancer genomics but struggles with reliable fusion gene detection.
- Long-read sequencing (LRS) shows promise for fusion transcript identification, yet faces persistent challenges.
Purpose of the Study:
- To develop and optimize a nanopore sequencing workflow for precise identification of fusion transcripts.
- To enhance the accuracy and mitigate biases in fusion gene analysis for clinical applications.
Main Methods:
- Utilized nanopore sequencing technology with a tailored library preparation protocol.
- Implemented a dedicated data processing and fusion gene analysis pipeline.
- Evaluated performance using Universal Human Reference RNA and human adenocarcinoma cell lines.
Main Results:
- Generated high-quality, full-length transcriptome data with extended length distribution and comprehensive coverage.
- Confirmed novel fusion events with potential clinical relevance through validation experiments.
- Demonstrated an optimized workflow for accurate fusion transcript identification.
Conclusions:
- The optimized nanopore sequencing workflow precisely identifies fusion transcripts, improving accuracy over existing methods.
- This protocol facilitates increased adoption in clinical diagnostics for cancer genomics.
- Advancements in LRS, including this workflow, promise deeper insights into fusion gene biology and enhanced cancer diagnostics.

